ABVC (ABVC BioPharma) EPS (Diluted): $-0.39 (TTM As of Mar. 2026)

What is ABVC BioPharma EPS (Diluted)?

ABVC BioPharma ABVC +6.25% 17 EPS (Diluted) is $-0.39 as of Mar. 2026. GuruFocus rates ABVC with a GF Score™ of 17/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 1 warning sign investors should review.

ABVC BioPharma's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was $-0.06. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.39.

ABVC BioPharma's EPS (Basic) for the three months ended in Mar. 2026 was $-0.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.39.

ABVC BioPharma's EPS without NRI for the three months ended in Mar. 2026 was $-0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.35.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

ABVC BioPharma (NAS:ABVC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ABVC BioPharma EPS (Diluted) Related Terms

ABVC BioPharma EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for ABVC BioPharma's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABVC BioPharma EPS (Diluted) Chart

ABVC BioPharma Annual Data

Trend

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Diluted)

Get a 7-Day Free Trial

-5.10

-5.19

-1.80

-0.42

-0.39

ABVC BioPharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Diluted)	Get a 7-Day Free Trial															-0.06	-0.13	-0.09	-0.11	-0.06

ABVC vs GRDX, INMB, ALGS: EPS (Diluted) Comparison

For the Biotechnology subindustry, ABVC BioPharma's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABVC BioPharma PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABVC BioPharma's PE Ratio distribution charts can be found below:

* The bar in red indicates where ABVC BioPharma's PE Ratio falls into.

Save Embed

17GF Score

ABVC BioPharma Inc ABVC

EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ABVC BioPharma EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

ABVC BioPharma's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-7.909	-	0)	/	20.109
	=	-0.39

ABVC BioPharma's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-1.56	-	0)	/	25.449
	=	-0.06

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.39

Frequently Asked Questions Learn more about EPS (Diluted) →

What does a EPS (Diluted) of $-0.39 mean?

ABVC BioPharma (ABVC) has a EPS (Diluted) of $-0.39 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on ABVC BioPharma and its competitors.

Is ABVC BioPharma's EPS (Diluted) too high?

ABVC BioPharma's current EPS (Diluted) is $-0.39. Overall, ABVC BioPharma has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does ABVC BioPharma's EPS (Diluted) compare to GRDX and INMB?

ABVC BioPharma's EPS (Diluted) of $-0.39 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Diluted) for a Biotechnology company?

A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Diluted) mean?

A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on ABVC BioPharma and its competitors. ABVC BioPharma's current EPS (Diluted) is $-0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ABVC BioPharma stock overvalued right now?

Based on GuruFocus' analysis, ABVC BioPharma (ABVC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $1.53 — trading 75.9% above its estimated fair value. The current EPS (Diluted) is $-0.39. ABVC BioPharma's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Diluted) calculated?

EPS (Diluted) is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current EPS (Diluted) is $-0.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABVC BioPharma (ABVC) Overvalued in 2026?

Based on GuruFocus' analysis, ABVC BioPharma stock appears to be overvalued. The current stock price of $1.53 is trading 75.9% above its estimated GF Value™ of $0.87. GuruFocus considers ABVC BioPharma to be Significantly Overvalued.

Key valuation signals for ABVC:

EPS (Diluted): $-0.39
GF Value™: $0.87 vs. price of $1.53 (75.9% above fair value)
GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the ABVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ABVC BioPharma Business Description

Industry Healthcare Biotechnology

Comparable Companies GRDX INMB ALGS VERU LITS ATNM DARE GRCE PSTV TVGN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538

Website https://www.abvcpharma.com

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

17GF Score

Get the complete analysis for ABVC

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.53

Price

$0.87

GF Value

View ABVC Analysis

See EPS (Diluted) data for all stocks →